Scientists are closely watching the drug , a investigational antibody targeting tau tangles , a significant hallmark of the debilitating disease . Unlike many past efforts focused on amyloid plaques, https://semorinemab-in-stock-rea159913.aboutyoublog.com/54327688/semorinemab-a-emerging-hope-for-the-condition